Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 21, 2012; 18(19): 2334-2343
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2334
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2334
Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells
Shuang-Fen Tao, Chang-Song Zhang, Xian-Ling Guo, Yun Xu, Shan-Shan Zhang, Jian-Rui Song, Rong Li, Meng-Chao Wu, Li-Xin Wei, Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China
Chang-Song Zhang, Clinical Oncology Laboratory, Changzhou Tumor Hospital, Medical College of Suzhou University, Changzhou 213001, Jiangsu Province, China
Author contributions: Tao SF, Zhang CS, Guo XL contributed equally to this work; Zhang CS and Guo XL designed the research; Xu Y, Zhang SS and Song JR performed the research; Li R and Wu MC analyzed the data; Tao SF and Wei LX wrote the paper.
Supported by The National Natural Science Foundation of China, No. 30901722, 30973433, 81000970, 81030041, 31171321 and 81101622
Correspondence to: Li-Xin Wei, MD, PhD, Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, 225 Changhai Road, Shanghai 200438, China. lixinwei@smmu.edu.cn
Telephone: +86-21-81875331 Fax: +86-21-65566349
Received: July 8, 2011
Revised: December 7, 2011
Accepted: December 14, 2011
Published online: May 21, 2012
Revised: December 7, 2011
Accepted: December 14, 2011
Published online: May 21, 2012
Core Tip